EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access · CC BY-NC-ND 4.0

Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial

Joseph Campain iD, Catharine Griskowitz iD, Chloe Newlands, Brian L Claggett iD, Ian J Kulac iD, Shaina McGinnis, Ilya Giverts iD, Fabely Moreno, Alexandra Minasian, Cheshta Prasad iD, Lillian Rupert iD, Isabela Landsteiner und 12 weitere

Circulation · 2025

DOI: 10.1161/circulationaha.124.073585 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, 2025. Verfasst von Joseph Campain und 23 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA (J.C., C.G., C.N., S.M., I.G., F.M., A.M., C.P., L.R…. Hauptthemen laut MEDLINE: Oxygen Consumption, Cardiomyopathy, Hypertrophic, Heart Failure, Exercise Tolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Post-exercise oxygen uptake recovery (VO 2 Rec) is slow in advanced heart failure. We sought to establish easily derived VO 2 Rec measures and evaluate their cardiospecificity and prognostic relevance in patients with dyspnea on exertion. We further sought to determine VO 2 Rec modifiability proportional to changes in cardiac function with disease-specific treatment of obstructive hypertrophic cardiomyopathy. METHODS: VO 2 Rec patterns were evaluated in relation to cardiac performance and the primary outcome of heart failure hospitalization or death in a referral cohort with dyspnea on exertion undergoing cardiopulmonary exercise testing with hemodynamic monitoring (MGH-ExS [Massachusetts General Hospital Exercise Study]). We then investigated longitudinal measures of VO 2 Rec in the pivotal phase 3 randomized controlled trial SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in Hypertrophic Cardiomyopathy) of aficamten versus placebo for 24 weeks in participants with symptomatic obstructive hypertrophic cardiomyopathy. For both cohorts, VO 2 Rec was uniformly measured as time for VO 2 to decline by >0%, 12.5% (VO 2 T 12.5% ), 25%, and 50% of peak VO 2 . RESULTS: Among 814 MGH-ExS patients (58±16 years of age, 58% women), those with a longer VO 2 T 12.5% (≥35 versus

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxygen ConsumptionCardiomyopathy, HypertrophicHeart FailureExercise ToleranceExerciseHumansFemaleMaleMiddle AgedAgedExercise TestRecovery of Function

Stichwörter der Autor:innen

aficamtencardiac myosincardiomyopathy, hypertrophicexercise testheart failure, diastolicpost-exercise recovery

Autor:innen und Institutionen

  • Heart and Vascular Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA (J.C., C.G., C.N., S.M., I.G., F.M., A.M., C.P., L.R., I.L., N.I., R.M., G.D.L.).
  • Cardiology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (B.L.C., I.J.K.).
  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom (C.J.C., M.M.Y.L.).
  • Lahey Hospital and Medical Center, Burlington, MA (M.S.M.).
  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (A.T.O.).
  • Cytokinetics, Inc., South San Francisco, CA (D.L.J., S.B.H., S.K., F.I.M., A.W.).

ORCID-Profile: Joseph Campain, Catharine Griskowitz, Brian L Claggett, Ian J Kulac, Ilya Giverts, Cheshta Prasad, Lillian Rupert, Caroline J Coats, Matthew M Y Lee, Martin S Maron, Anjali T Owens, Daniel L Jacoby, Stephen B Heitner, Stuart Kupfer, Fady I Malik, Rajeev Malhotra, Gregory D Lewis

Zitieren

APA

Campain, J., Griskowitz, C., Newlands, C., Claggett, B. L., Kulac, I. J., McGinnis, S., Giverts, I., Moreno, F., Minasian, A., Prasad, C., Rupert, L., Landsteiner, I., Iskenderian, N., Coats, C. J., Lee, M. M. Y., Maron, M. S., Owens, A. T., Jacoby, D. L., Heitner, S. B., …, & Lewis, G. D. (2025). Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial. Circulation. https://doi.org/10.1161/circulationaha.124.073585

Vancouver

Campain J, Griskowitz C, Newlands C, Claggett BL, Kulac IJ, McGinnis S, et al. Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial. Circulation. 2025. doi:10.1161/circulationaha.124.073585

BibTeX
@article{Campain2025,
  author = {Campain, Joseph and Griskowitz, Catharine and Newlands, Chloe and Claggett, Brian L and Kulac, Ian J and McGinnis, Shaina and Giverts, Ilya and Moreno, Fabely and Minasian, Alexandra and Prasad, Cheshta and Rupert, Lillian and Landsteiner, Isabela and Iskenderian, Nick and Coats, Caroline J and Lee, Matthew M Y and Maron, Martin S and Owens, Anjali T and Jacoby, Daniel L and Heitner, Stephen B and Kupfer, Stuart and Malik, Fady I and Wohltman, Amy and Malhotra, Rajeev and Lewis, Gregory D},
  title = {Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial},
  journal = {Circulation},
  year = {2025},
  doi = {10.1161/circulationaha.124.073585}
}
Kostenlos starten →